Pando Bioscience (YC W23) Information

Pando Bioscience is a synthetic biology platform company aiming to dramatically expand the understanding of human diseases from genomes to interactomes, from individual proteins to protein-protein interaction (PPI) networks. Our multi-dimensional cell-based and AI-powered platform identifies critical disease-related protein-protein interactions for future therapies, and most importantly, discovers PPI-targeting drugs. We are starting with cancer, but our platform can be applied to a wide range of disorders like heart, respiratory, and neurological diseases. For general questions, or to learn more about collaborations and partnerships, don’t hesitate to reach out at founders@pando.bio